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Available online 11 May 2016Expanded human T cells from a Japanese healthy male were used to generate integration-free induced pluripo-
tent stem cells (iPSCs) by exogenous expression of four reprogramming factors, OCT3/4, SOX2, cMYC, KLF4, using
Sendai virus vector (SeVdp). The authenticity of established iPSC line, WT-iPSC1, was conﬁrmed by the expres-
sions of stem cell markers and the differentiation capability into three germ layers. WT-iPSC1 may be a useful
cell resource as a normal control for the comparative study using disease-speciﬁc iPSCs.
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Expanded T cells isolated from a 38 year-old Japanese healthy male
were reprogrammed employing Sendai virus vectors (SeVdp) express-
ing four reprogramming factors, OCT3/4, SOX2, cMYC, KLF4. SeVdp is in-
tegration-free vector, and the absence of reprogramming genes in
established iPSC line, WT-iPSC1, was conﬁrmed by PCR analysis (Fig.. This is an open access article under1A). DNA ﬁngerprint analysis ofWT-iPSC1 and expanded T cells provid-
ed the origin of cell source (Fig. 1B). The authenticity of WT-iPSC1 was
conﬁrmed by the followings; (1) the expression of stem cell markers
by immunostaining (Fig. 1C) and RT-PCR (Fig. 1D), (2) the differentia-
tion capability into three germ layers using in vitro differentiation
through embryoid bodies (EBs) and teratoma formation (Fig. 1E). In ad-
dition,WT-iPSC1maintains normal karyotype (46, XY) (Fig. 1F), and Bi-
sulﬁte sequencing revealed that the NANOG promoter region in WT-
iPSC1 was unmethylated (Fig. 1G).
Materials and methods
Cell culture
Monocyteswere isolated froma volunteer's peripheral blood sample
using SepMate-50 (STEMCELL Technologies, Inc., Canada) and Ficoll-
Paque Plus (GE Healthcare). Consequently, T cell was expanded in TLY
culture kit (LYMPHOTEC, Inc., Japan) for 5–10 days at 37 °C at 5% CO2.
iPSC generation
Expanded T cells were reprogrammed by SeVdp as previously de-
scribed (Nishimura et al., 2011; Itoh et al., 2016). Brieﬂy, the transfected
cellswere seeded on feeder cell layer in RPMI1640with 10% fetal bovine
serum and interleukin-2 (PeproTech). After 2 days, the medium was
changed to Primate ES cell culturemedium (ReproCELL Inc., Japan) sup-
plemented with basic ﬁbroblast growth factor (bFGF) (5 ng/mL, R&D
Systems), and cultured until colonies appeared. Established iPSCs
were maintained in human iPS cell medium (Itoh et al., 2016). To
completely remove SeVdp, siRNA mixture (Itoh et al., 2016) was
added several times into the medium.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. Characterization of WT-iPSC1. (A) Conﬁrmation of the absent of SeVdp-related
reprogramming gene by RT-PCR (M: marker, #1:WT-iPSC1, C: control transfected cell sam-
ple). (B) DNA ﬁngerprint analysis by RT-PCR identiﬁed the origin of WT-iPSC1 (M: marker,
Red square:WT-iPSC1 genomic DNA, G: genomic DNA isolated from original T cells, C: geno-
mic DNA isolated from a different individual). The expression of stem cell markers in WT-
iPSC1 was detected by immunostaining (C) and RT-PCR (D) (Red square: WT-iPSC1 cDNA,
E: embryonic stem cell cDNA,M:monocyte cDNA). (E) Embryoid body and teratoma forma-
tion indicated the differentiation capability into three germ layer, ectoderm (βIII-tubulin and
neural epithelium), mesoderm (vimentin and cartilage) and endoderm (α-fetoprotein and
gut epithelium). (F) Karyotype was normal (46, XY). (G) The NANOG promoter region in
WT-iPSC1 was almost completely unmethylated (White circle: unmethylated CpGs, black
circle: methylated CpGs). All the data suggested the authenticity of WT-iPSC1.
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DNA ﬁngerprint analysis was performed by PCR ampliﬁcation with
speciﬁc primers supplied in (Itoh et al., 2011).
RT-PCR and PCR
RNAwas extracted using an RNeasy Mini Kit (Qiagen), and comple-
mentary DNAwas synthesized using 2 μg RNA by SuperScript III reverse
transcriptase and Oligo-dT primer (Invitrogen) according to the
manufacturer's instructions. PCR reactions were performed with Plati-
num PCR SuperMix (Invitrogen). All primer sequences are supplied in
(Itoh et al., 2011) and (Itoh et al., 2016).Immunostaining
iPSCs and EBs were ﬁxed with 4% paraformaldehyde(PFA)/PBS and
permeabilized with 0.1% Triton-×100/PBS. After blocking using 10%
goat sera/PBS, samples were incubated for 1 h at room temperature
(RT) or overnight at 4 °C with primary antibodies. After three rinses
with PBS, incubation with appropriate secondary antibodies was per-
formed for 1 h at RT. Nuclei stainingwas performedwith Hoechst33342
(1:1000, Fisher Scientiﬁc)/PBS. Conforcal microscopy (OLYMPUS FV-
300) was used to visualize and capture the immunostained cells with
good resolution. All antibodies are supplied in (Itoh et al., 2016).
Karyotyping analysis
Karyotyping analysis was offered to Nihon Gene Research Laborato-
ries, Inc., Japan.
Methylation assay
A total of 1 μg genomic DNA extracted fromWT-iPSC1 was treated
with EZ DNAMethylation-Gold Kit (ZYMO Research, Corp.) for bisulﬁte
reaction. The promoter region of theNANOG genewas ampliﬁed by PCR
using gene-speciﬁc primers (Itoh et al., 2011). PCR product was
subcloned into pCR2.1 vector (Invitrogen), and 10 clones were se-
quenced for deﬁningmethylation status of theNANOG promoter region.
In vitro differentiation
EBs were made in hiPSCM without bFGF as previously described in
(Itoh et al., 2011) For enhancing spontaneous differentiation, EBs were
attached on gelatin-coated chamber slides and incubated in DMEM
with 10% FBS for 14 days before immunostaining.
Teratoma formation
Colonies of WT-iPSC1 were collected by 1 mg/mL collagenase IV
(Invitrogen) treatment and subcutaneously injected into nude mice
(CLEA Japan, Inc.)withMatrigel (Corning, Inc.). Palpable tumors typical-
ly appeared 1–2 months after injection. Tumors were collected and
processed for H&E staining according to standard procedures to check
their differentiation capacity into all three germ layers in vivo.
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